on INNATE PHARMA (EPA:IPH)
Results of the Combined General Meeting of Innate Pharma
Marseille, May 23, 2024, Innate Pharma SA announced the results of the shareholder vote during the Combined General Meeting. All resolutions were adopted. 84 votes were cast out of a total of 36,317,268 shares, representing a quorum of 44.92% of the voting rights.
The two members of the Supervisory Board, whose renewal was proposed, were re-elected. Details of the resolutions, the result of the voting per resolution, and other documents relating to the General Meeting are available on the Company's website.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news